Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Oncolytics Biotech Inc (ONCY)

Oncolytics Biotech Inc (ONCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Stocks in play: Oncolytics Biotech Inc Baystreet - Fri Jan 16, 12:13PM CST

Today announced the voting results from its Special Meeting of Shareholders held on Thursday, January ...

ONCY : 1.0100 (+3.80%)
Oncolytics Biotech® Announces Results of Special Meeting of Shareholders GlobeNewswire - Thu Jan 15, 3:01PM CST

SAN DIEGO, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Oncolytics Biotech ® Inc. (Nasdaq: ONCY) (“ Oncolytics ” or the “ Company ”), a clinical-stage immunotherapy company developing pelareorep, today...

ONCY : 1.0100 (+3.80%)
The $69B Precision Pivot: Why Biomarker Platforms are Igniting a New Oncology Gold Rush BayStreet.ca - Wed Jan 14, 8:56AM CST

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – Baystreet.ca News Commentary – The genomics in cancer care market is on a massive tear, projected to hit $69.16 billion by 2032 as doctors...

ONCY : 1.0100 (+3.80%)
BCT.TO : 5.97 (-4.48%)
ACRV : 1.9800 (+5.88%)
LLY : 1,038.40 (+0.53%)
BCTX : 4.29 (-4.45%)
GLSI : 24.88 (-8.50%)
CATX : 2.33 (-6.05%)
Oncolytics Biotech® Appoints John McAdory as EVP of Strategy and Operations and Yujun Wu to Lead Biostatistics GlobeNewswire - Wed Jan 14, 8:00AM CST

SAN DIEGO, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Oncolytics Biotech ® Inc. (Nasdaq: ONCY) (“Oncolytics” or the “Company”), a clinical-stage immunotherapy company developing pelareorep, today announced...

ONCY : 1.0100 (+3.80%)
CGON : 54.73 (+3.13%)
TAK : 16.16 (-1.04%)
Stocks in play: Oncolytics Biotech Inc Baystreet - Mon Jan 12, 9:22AM CST

Announced updated clinical data from GOBLET Cohort 4 in patients with third-line metastatic squamous ...

ONCY : 1.0100 (+3.80%)
Oncolytics Biotech® Announces Updated Clinical Data from GOBLET Cohort 4 Demonstrating Activity of Pelareorep Plus Atezolizumab in Third-Line Anal Cancer GlobeNewswire - Mon Jan 12, 8:00AM CST

Compared to the historical benchmark, pelareorep-atezolizumab nearly tripled ORR  Combination achieved encouraging median DOR of almost 17 months Data establishes clear path in indication with...

ONCY : 1.0100 (+3.80%)
Stocks in play: Oncolytics Biotech Inc. Baystreet - Fri Jan 9, 9:53AM CST

Announced proposal to change the Company’s jurisdiction of incorporation from Alberta, Canada, to the ...

ONCY : 1.0100 (+3.80%)
Oncolytics Biotech® Outlines Strategic Rationale for Proposal to Change Jurisdiction of Incorporation to Nevada GlobeNewswire - Fri Jan 9, 8:00AM CST

SAN DIEGO, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Oncolytics Biotech ® Inc. (Nasdaq: ONCY) (“ Oncolytics ” or the “ Company ”), a clinical-stage immunotherapy company developing pelareorep, today...

ONCY : 1.0100 (+3.80%)
The $537B Precision Pivot: Why Molecular Monitoring is the New Oncology Standard BayStreet.ca - Thu Jan 8, 10:36AM CST

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – Baystreet.ca News Commentary – The war on cancer is moving into a high-tech era of molecular-guided defense. The genomics in cancer care...

ONCY : 1.0100 (+3.80%)
PYXS : 1.7600 (-4.35%)
PSNL : 9.89 (+2.91%)
NBP : 3.73 (+1.91%)
TOI : 3.35 (-0.30%)
Stocks in play: Oncolytics Biotech Inc Baystreet - Wed Jan 7, 10:31AM CST

Announced the expansion of its gastrointestinal Tumor Scientific Advisory Board with the appointment ...

ONCY : 1.0100 (+3.80%)

Barchart Exclusives

As Apple Teams Up with Google on Siri AI Upgrades, Should You Buy AAPL Stock? Barchart - 18 minutes ago
Apple’s decision to tap Google’s Gemini AI to supercharge Siri is redefining its AI strategy. Is AAPL a buy now? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot